Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Stocks / IPOs
 Search News  Or
Shanghai Fosun Pharma approved for HK IPO

Apr. 25, 2012 (China Knowledge) - Shanghai Fosun Pharmaceutical (Group) Co<600196>, the medical subsidiary of Fosun International Ltd<0656>, China's largest privately-owned conglomerate, has received approval from regulators to launch its initial public offering in Hong Kong with fundraising of not more than US$800 million.

A person familiar with the matter said the pharmaceutical firm has yet made out timetable for the IPO but has no plans to start the IPO recently. In the proposed IPO, not more than 547 million H shares would be issued, the person added.

In January 2012, the company reduced its IPO size from US$1 billion it forecasted last March to not more than US$800 million, as its A share price declined 37% last year, underperforming the Shanghai Composite index with a decline of 22%.

The firm's A shares, however, grew 14% since the start of the year.

J.P. Morgan Chase & Co, Deutsche Bank AG and China International Capital Corporation Ltd have been assigned to handle the deal, sources reported.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved